A Perspective Study of the Antiviral Efficacy and Safety of Switching to TAF Treatment in CHB Adults With Suboptimal Response (SOR) and Intolerant to Entecavir

Name: A Perspective Study of the Antiviral Efficacy and Safety of Switching to TAF Treatment in CHB Adults With Suboptimal Response (SOR) and Intolerant to Entecavir
Published: 2019
License: Public Domain

The First Hospital of Jilin University · 2019

ClinicalTrials.gov · Datasets · License: Public Domain · 2019

Open Source ↗

hbv, interventional, phase4

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Perspective Study of the Antiviral Efficacy and Safety of Switching to TAF Treatment in CHB Adults With Suboptimal Response (SOR) and Intolerant to Entecavir

Related documents